Milestone Advisory Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$285K Hold
1,950
0.24% 55
2023
Q2
$299K Hold
1,950
0.27% 53
2023
Q1
$302K Hold
1,950
0.28% 53
2022
Q4
$301K Hold
1,950
0.22% 55
2022
Q3
$257K Hold
1,950
0.19% 57
2022
Q2
$271K Hold
1,950
0.22% 54
2022
Q1
$291K Hold
1,950
0.16% 68
2021
Q4
$316K Buy
+1,950
New +$315K 0.16% 63
2021
Q3
Sell
-1,950
Closed -$337K 84
2021
Q2
$337K Hold
1,950
0.18% 61
2021
Q1
$313K Hold
1,950
0.17% 51
2020
Q4
$328K Buy
+1,950
New +$316K 0.19% 44
2020
Q2
Sell
-1,950
Closed -$256K 57
2020
Q1
$256K Hold
1,950
0.18% 35
2019
Q4
$290K Hold
1,950
0.15% 46
2019
Q3
$241K Hold
1,950
0.14% 52
2019
Q2
$275K Hold
1,950
0.17% 45
2019
Q1
$294K Hold
1,950
0.19% 41
2018
Q4
$237K Hold
1,950
0.21% 38
2018
Q3
$309K Hold
1,950
0.22% 39
2018
Q2
$273K Hold
1,950
0.2% 40
2018
Q1
$259K Hold
1,950
0.19% 42
2017
Q4
$243K Buy
+1,950
New +$241K 0.18% 43

Other funds holding FBT

Milestone Advisory Partners's FBT Position: Q3 2023 in Review

Milestone Advisory Partners held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2023 at 1,950 shares worth $285K. The position accounts for 0.24% of the portfolio, ranked #55.

Milestone Advisory Partners first reported a position in FBT in Q4 2017 and has held it in 21 quarters since. The position peaked at $337K in Q2 2021. 242 funds tracked by Wall St. Rank hold FBT as of Q3 2023.

  • Milestone Advisory Partners held 1,950 shares of First Trust NYSE Arca Biotechnology Index Fund worth $285K as of Q3 2023.
  • Milestone Advisory Partners left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2023.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.24% of Milestone Advisory Partners's portfolio in Q3 2023, its #55 holding.
  • Milestone Advisory Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and has held it in 21 quarters since.
  • Milestone Advisory Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $337K in Q2 2021.
  • 242 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2023.

Based on Milestone Advisory Partners's 13F filing for Q3 2023, filed 8 Nov 2023.